| scholarly article | Q13442814 |
| P2093 | author name string | Health Quality Ontario | |
| P2860 | cites work | Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding | Q61698711 |
| Hysterectomy rates in the United States 1990–1997 | Q62026049 | ||
| The effects of danazol, mefenamic acid, norethisterone and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia | Q69456673 | ||
| Sources of variation in menstrual blood loss | Q70580736 | ||
| Menstrual Blood Loss–A Population Study: Variation at different ages and attempts to define normality | Q72808966 | ||
| Assessment of menstrual blood loss using a pictorial chart: a validation study | Q73599964 | ||
| Perforations with intrauterine devices. Report from a Swedish survey | Q74741097 | ||
| Incidence of cyclical bleeding after laparoscopic supracervical hysterectomy | Q81795346 | ||
| Long-term outcomes following laparoscopic supracervical hysterectomy | Q81887821 | ||
| Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding: diagnostic accuracy compared to alkaline hematin | Q83179519 | ||
| Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding improves hemoglobin and ferritin levels | Q84949836 | ||
| Postablation risk factors for pain and subsequent hysterectomy | Q86087042 | ||
| Cost-utility of levonorgestrel intrauterine system compared with hysterectomy and second generation endometrial ablative techniques in managing patients with menorrhagia in the UK | Q94533822 | ||
| Prevalence of self-reported hysterectomy among Canadian women, 2000/2001-2008 | Q95564143 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 | ||
| Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding | Q24186336 | ||
| Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding | Q24201559 | ||
| Cyclical progestogens for heavy menstrual bleeding | Q24242472 | ||
| Surgery versus medical therapy for heavy menstrual bleeding | Q24248731 | ||
| The MOS 36-ltem Short-Form Health Survey (SF-36) | Q26778425 | ||
| EuroQol--a new facility for the measurement of health-related quality of life | Q29547873 | ||
| GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology | Q29619792 | ||
| The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review | Q32048500 | ||
| Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial | Q32050584 | ||
| Menstrual suppression in special circumstances | Q33418585 | ||
| Supracervical hysterectomy | Q33549975 | ||
| Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients | Q33659887 | ||
| Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy | Q33775919 | ||
| Questioning our questions: do frequently asked questions adequately cover the aspects of women's lives most affected by abnormal uterine bleeding? Opinions of women with abnormal uterine bleeding participating in focus group discussions | Q33908942 | ||
| Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection | Q34085320 | ||
| An epidemiological survey of symptoms of menstrual loss in the community. | Q34098791 | ||
| Levonorgestrel-releasing intrauterine system versus medical therapy for menorrhagia: a systematic review and meta-analysis | Q34272696 | ||
| Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up | Q34308164 | ||
| Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy | Q34331501 | ||
| The levonorgestrel-releasing intrauterine system as an alternative to hysterectomy in peri-menopausal women | Q34631979 | ||
| A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding | Q34632172 | ||
| Abnormal uterine bleeding in pre-menopausal women | Q34767229 | ||
| Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis | Q34857094 | ||
| Levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation (Novasure) in women with heavy menstrual bleeding: a multicentre randomised controlled trial | Q34910787 | ||
| Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis | Q34977130 | ||
| Levonorgestrel-releasing intrauterine system vs. usual medical treatment for menorrhagia: an economic evaluation alongside a randomised controlled trial | Q35123197 | ||
| A randomized clinical trial to compare levonorgestrel-releasing intrauterine system (Mirena) vs trans-cervical endometrial resection for treatment of menorrhagia | Q35147309 | ||
| Endometrial ablation in the management of abnormal uterine bleeding. | Q35639680 | ||
| A systematic review comparing hysterectomy with less-invasive treatments for abnormal uterine bleeding | Q35719158 | ||
| A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial. | Q35823434 | ||
| Thermal balloon endometrial ablation for dysfunctional uterine bleeding: an evidence-based analysis. | Q36070764 | ||
| Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview | Q36330350 | ||
| Pregnancy after endometrial ablation: English literature review and case report | Q36417555 | ||
| Cost-effectiveness of treatments for dysfunctional uterine bleeding in women who need contraception | Q36563879 | ||
| The levonorgestrel intrauterine system in nulliparous women | Q36832734 | ||
| Long-term complications of endometrial ablation: cause, diagnosis, treatment, and prevention | Q36881063 | ||
| Thermal balloon endometrial ablation: a systematic review | Q36931699 | ||
| The experience of heavy menstrual bleeding: a systematic review and meta-ethnography of qualitative studies | Q37276170 | ||
| The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability. | Q37298238 | ||
| Pregnancy After Hysteroscopic Endometrial Ablation Without Endometrial Preparation: A Report of Five Cases and a Literature Review | Q37807721 | ||
| Efficacy of contraceptive methods: a review of the literature | Q37810973 | ||
| Cost-effectiveness and quality of life associated with heavy menstrual bleeding among women using the levonorgestrel-releasing intrauterine system | Q37832562 | ||
| Hysterectomy, endometrial ablation and Mirena® for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis | Q37871108 | ||
| The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review | Q37977978 | ||
| Medical treatment of idiopathic heavy menstrual bleeding. What is new? An evidence based approach | Q38057112 | ||
| Retrospective analysis of variation in heavy menstrual bleeding treatments by age and underlying cause | Q38069897 | ||
| Complications of hysterectomy | Q38103348 | ||
| Hormonal contraception as treatment for heavy menstrual bleeding: a systematic review | Q38260106 | ||
| Medical management of heavy menstrual bleeding: a comprehensive review of the literature. | Q38351761 | ||
| Barriers and Misperceptions Limiting Widespread Use of Intrauterine Contraception Among Canadian Women | Q38586339 | ||
| Cost-effectiveness analysis in the treatment of heavy menstrual bleeding in Spain | Q39086012 | ||
| Regional differences in obesity. | Q39768965 | ||
| Economic evaluation of the levonorgestrel-releasing intrauterine system for the treatment of dysfunctional uterine bleeding in Spain. | Q39827115 | ||
| Levonorgestrel intrauterine system: a first-line medical treatment for heavy menstrual bleeding | Q39878679 | ||
| Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices | Q41560550 | ||
| The meaning of menorrhagia: an investigation into the association between the complaint of menorrhagia and depression | Q41609213 | ||
| Use of other treatments before hysterectomy for benign conditions in a statewide hospital collaborative. | Q41647027 | ||
| Cost-effectiveness analysis of levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding | Q42690741 | ||
| Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial | Q42928363 | ||
| A randomized prospective trial comparing the levonorgestrel-releasing intrauterine system with thermal balloon ablation for the treatment of heavy menstrual bleeding | Q43160580 | ||
| Assessment of menstrual blood loss using a pictorial chart | Q43313518 | ||
| The levonorgestrel intrauterine system as an alternative to hysterectomy for the treatment of idiopathic menorrhagia | Q43369533 | ||
| Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland | Q43727598 | ||
| A randomized controlled trial of levonorgestrel releasing IUD and thermal balloon ablation in the treatment of menorrhagia | Q44039042 | ||
| Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy | Q44182101 | ||
| Comparison between the levonorgestrel intrauterine system (LNG-IUS) and thermal balloon ablation in the treatment of menorrhagia | Q44403321 | ||
| Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia | Q44442562 | ||
| Five-year follow-up of levonorgestrel-releasing intrauterine system versus thermal balloon ablation for the treatment of heavy menstrual bleeding: a randomized controlled trial. | Q44554284 | ||
| A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia | Q44683154 | ||
| Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection | Q45168795 | ||
| The effect of levonorgestrel-releasing intrauterine device on menorrhagia in women taking anticoagulant medication after cardiac valve replacement. | Q45920157 | ||
| A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia. | Q45982568 | ||
| Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment cha | Q46619982 | ||
| Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomized, prospective, controlled clinical trial in female smokers | Q46663357 | ||
| Quality of life and costs of levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of menorrhagia: a 10-year randomized controlled trial | Q46761970 | ||
| Uterine perforation in women using a levonorgestrel-releasing intrauterine system | Q46939887 | ||
| A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding | Q46951039 | ||
| A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia | Q46967146 | ||
| Levonorgestrel intrauterine system versus medical therapy for menorrhagia | Q47574691 | ||
| Effects of anemia and iron deficiency on quality of life in women with heavy menstrual bleeding | Q47863997 | ||
| Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia | Q47910290 | ||
| Factors predicting choice of treatment for menorrhagia in gynaecology outpatient clinics | Q48032236 | ||
| The cost-effectiveness of the levonorgestrel-releasing intrauterine system for the treatment of idiopathic heavy menstrual bleeding in the United States | Q48270626 | ||
| Levonorgestrel-releasing intrauterine system versus laparoscopic supracervical hysterectomy for the treatment of heavy menstrual bleeding: a randomized study. | Q48452972 | ||
| The measurement properties of the menorrhagia multi-attribute quality-of-life scale: a psychometric analysis | Q48623348 | ||
| Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial | Q48736440 | ||
| Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis | Q48762670 | ||
| Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia. | Q50956819 | ||
| Health status function after treatment with thermal balloon endometrial ablation and levonorgestrel intrauterine system for idiopathic menorrhagia: a randomized study. | Q51227002 | ||
| A cost-utility analysis of hysterectomy, endometrial resection and ablation and medical therapy for menorrhagia. | Q51234797 | ||
| Complications of the intrauterine device in nulliparous and parous women. | Q51584014 | ||
| Analysis of risk factors associated with uterine perforation by intrauterine devices. | Q51787066 | ||
| A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. | Q52242359 | ||
| Perceptions of women on the impact of menorrhagia on their health using multi-attribute utility assessment. | Q53564507 | ||
| Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement | Q56880247 | ||
| Effects of Decision Aids for Menorrhagia on Treatment Choices, Health Outcomes, and Costs | Q57699876 | ||
| P433 | issue | 18 | |
| P921 | main subject | IUD with progestogen | Q1628262 |
| P304 | page(s) | 1-119 | |
| P577 | publication date | 2016-11-01 | |
| P1433 | published in | Ontario health technology assessment series | Q27722839 |
| P1476 | title | Levonorgestrel-Releasing Intrauterine System (52 mg) for Idiopathic Heavy Menstrual Bleeding: A Health Technology Assessment | |
| P478 | volume | 16 |
Search more.